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Abstract
Despite that a wealth of evidence links striatal dopamine to individuals reward learning performance in non-social
environments, the neurochemical underpinnings of such learning during social interaction are unknown. Here, we show
that the administration of 300 mg of the dopamine precursor L-DOPA to 200 healthy male subjects influences learning
about a partners’ prosocial preferences in a novel social interaction task, which is akin to a repeated trust game. We found
learning to be modulated by a well-established genetic marker of striatal dopamine levels, the 40-bp variable number
tandem repeats polymorphism of the dopamine transporter (DAT1 polymorphism). In particular, we found that L-DOPA
improves learning in 10/10R genoype subjects, who are assumed to have lower endogenous striatal dopamine levels and
impairs learning in 9/10R genotype subjects, who are assumed to have higher endogenous dopamine levels. These findings
provide first evidence for a critical role of dopamine in learning whether an interaction partner has a prosocial or a selfish
personality. The applied pharmacogenetic approach may open doors to new ways of studying psychiatric disorders such as
psychosis, which is characterized by distorted perceptions of others’ prosocial attitudes.
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Introduction
Finding generic prosocial interaction partners and distinguish-
ing them from selfish ones is of major importance in our social and
economic well-being. People learn about a partner’s prosocial
preferences by gathering information either through personal
interactions or by using information about the reputation of the
interaction partner [1]. When external information about some-
one’s prosocial preferences is not available, one has to learn this,
via trial and error, in repeated interactions with the partner [2].
However, strategic motives may overcast such learning, as they
create an incentive for selfish partners to appear prosocially in
order to be able to profit from future interactions.
Despite the fact that learning about a partners’ prosocial
preferences is a fundamental aspect of our everyday social lives,
little is yet known about the regional neurochemical systems that
influence learning in social contexts. So far, basic research in non-
human animals [3] and human neuroimaging studies using drug
challenges [4,5], as well as studies with individuals suffering from
Parkinson’s disease [6,7,8] have delineated the dopamine system
with a particular emphasis on the striatum as being a fundamental
basic neurocircuitry underlying probabilistic reward-learning in
humans. However, recent research has begun to probe the
involvement of the striatum in more complex behaviors typically
observed in repeated social interactions between two individuals.
For instance, human neuroimaging studies investigating the neural
correlates of repeated trust interactions have shown that positive
social feedback such as reciprocated trust activates an individual’s
striatum, whereas selfish, non-reciprocated trust leads to a
decrease in striatal activity [1,2], for a review see [9]. Furthermore,
activation in the striatum also predicts future trust decisions [10],
suggesting that striatal activity might signal the rewards of positive
social feedback and thereby guides future decisions. Thus, it
appears that reward learning based on social outcomes (e.g., social
approval, positive emotional responses and positive social feedback
in repeated interactions) is coded similarly in reward circuitry as if
feedback was based on non-social outcomes [11,12,13]. In sum,
there is much reason to believe that a pharmacological manipu-
lation of striatal dopamine modulates learning about others’
prosocial preferences by relying fundamentally on a basic
probabilistic reward-learning mechanism.
Striatal dopamine levels are dependent on the availability of the
dopamine transporter (DAT) protein, as it reuptakes dopamine
from the synaptic cleft into the pre-synaptic compartment after its
release. Therefore, DAT is an important regulator of dopamine
signaling, most primarily in the striatum, as it only occurs in low
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concentrations in other areas of the brain [14]. There is substantial
genetic variation in protein expression levels, and this variation is
assumed to affect endogenous striatal dopamine levels. The most
extensively studied gene variant in this context is the 40 base-pair
variable number tandem repeat polymorphism of the dopamine
transporter (DAT1 polymorphism) [15]. Basic neurobiological
research has shown that the 9-repeat (9R) variant of the DAT1
polymorphism is associated with lower transporter protein
expression than the 10R variant [16,17]. Neurochemical imaging
research in humans reported a lower density of dopamine
transporter in striatum of individuals who carry a 9/10R genotype
(heterozygotes) compared to those who carry the 10/10R
(homozygotes) genotype [18]. Hence, 9/10R genotype individuals
are expected to have higher extrasynaptic striatal dopamine levels
than 10/10R carriers [19,20,21,22]. Accordingly, functional
imaging studies have consistently reported that 9/10R genotype
carriers show greater activity in the striatum during processing of
rewards compared to 10/10R carriers [19,20,21]. Data stemming
from Parkinson’s disease patients who are treated with L-
dihydroxy-phenylalanine (L-DOPA, a biochemical precursor of
dopamine) suggest that the drug interacts with the DAT1
polymorphism in ways that are consistent with the above line of
arguments. Patients who carry the 9/10R genotype are more likely
to experience long term side-effects of L-DOPA treatment, which
can be linked to high levels of dopamine in the striatum, compared
to those who carry the 10/10R genotype [23].
Here we explore how L-DOPA induced increases in brain
dopamine levels interact with genetically determined individual
differences in endogenous striatal dopamine levels to influence
learning about a partners’ prosocial preferences. We administered
300 mg of L-DOPA to 205 subjects, who were all genotyped for
their DAT1 polymorphism (Materials S1). As L-DOPA is mainly
converted to dopamine in the striatum [24], endogenous striatal
dopamine levels might interact with exogenous administration of
L-DOPA to influence net dopamine levels [23]. Based on this line
of arguments, we test the hypothesis that the effects of L-DOPA
administration on learning about others’ prosociality depends on
an individual’s DAT1 polymorphism. A pharmacogenetic ap-
proach [25,26] allows a specific interpretation of the observed
effects, i.e. in the present context whether the DAT1 polymor-
phism is predictive of the direction of the effects of a pharmaco-
logical challenge on reward learning.
Materials and Methods
Subjects
205 healthy young Swiss males with mean (SD) age of 23.5 years
(3.6) took part in our double-blind, parallel group and placebo
controlled experiment. The study was performed in accordance
with the Declaration of Helsinki and approved by the Cantonal
Ethic Commission Zurich. Subjects had no significant general
psychiatric, medical, or neurological disorder based on the result
of structured interviews; they were included in the study after
having provided written informed consent. Three subjects were
excluded due to self-reported nausea, and two because they did
not understand the instructions.
Genotyping
The polymorphism for the DAT-1 was characterized using
PCR amplification procedure with the following primers:
DAT-1:
F59-TGTGGTGTAGGGAACGGCCTG-39.
R59-CTTCCTGGAGGTCACGGCTCA-39.
PCR reactions were performed using 5 ml Master Mix (Thermo
scientific), 2 ml primers (0.5 mM), 0.6 ml Mg/Cl2 (2.5 mM), 0.4 ml
DMSO 5% and 1 ml of water to total of 9 ml total volume and an
additional 1 ml of genomic DNA was added to the mixture. All
PCR reactions were employed on a Biometra T1 Thermocycler
(Biometra, Gu¨ttingem, Germany). PCR reaction conditions were
as follows:
Preheating step at 94.0˚C for 5 min, 34 cycles of denaturation at
94.0˚C for 30 s, reannealing at 55˚C for 30 s and extension at 72˚C
for 90 s. The reaction proceeded to a hold at 72˚C for 5 min. All
reaction mixtures were electrophoresed on a 3% agarose gel
(AMRESCO) with ethidium bromide to screen for genotype.
Subject Grouping According to DAT1 Polymorphism
The 9/10R and the 10/10R genotypes accounted for the
majority of the observed genotypes in our sample (48% and 44%,
respectively, Table 1), and we used these two genotypes
throughout the analyses. The system was in Hardy-Weinberg
equilibrium. The observed and expected heterozygosity were 0.88
and 0.79 respectively.
Experimental Procedure
Subjects were randomly assigned to receive either a single dose
of 300 mg of Madopar (consisting of 300 mg L-DOPA and 75 mg
benserazide, a peripheral dopa-decarboxylase inhibitor) or a
placebo. They then received a standardized meal and 100 ml of
water. On the evening before the experiment and 30 min before
L-DOPA administration, subjects were required to ingest 10 mg of
domperidone in order to avoid possible peripheral dopaminergic
side effects such as nausea and orthostatic hypotension. After
subjects had read the instructions, we checked whether they had
understood the rules of the game by providing control questions.
All but two of the subjects answered these control questions
correctly. Subjects performed the task 50 min after L-DOPA
intake. The task was implemented in z-Tree software and
presented on computer screens [27]. Subjects were also requested
to perform a mouthwash to collect buccal epithelial cells for the
preparation of DNA. All subjects received a flat fee of CHF 100
for participation in the experiment and an additional payment
according to the points earned in the task. Each point earned was
worth CHF 0.07. Each subject received payment in cash in private
at the end of the experiment, based on the points earned.
Experimental Design
In our paradigm, two players, player A and player B, begin with
an endowment of 10 monetary units (MUs). First, player A has to
decide how much of his endowment he wants to transfer to player
Table 1. DAT1 polymorphism allele frequencies in our
sample.
DAT1 polymorphism genotypes Placebo L-DOPA Total
10/10R 45 51 96
9/10R 46 42 88
9/9R 8 3 11
9/11R 1 2 3
7/10R 1 0 1
10/11R 0 1 1
Total 101 99 200
doi:10.1371/journal.pone.0067820.t001
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B, knowing that the transfer is tripled by the experimenter. The
transfer has an 80% probability of reaching player B. In this case,
B can choose to either make a repayment that equalizes payoffs, or
to retain the entire amount. The transfer is ‘‘lost’’ in the remaining
20% of the cases, so that player B receives nothing and cannot
make a repayment. Thus, in case of an omitted return, player A
does not know with 100% certainty whether this was player B’s
intention.
To be able to observe learning over time, we let our subjects in
the role of player A play several rounds of the task. Each player A
plays 20 rounds of the task paired with the same player B in all
rounds. Since an omitted return is an extremely powerful aversive
social signal, we implemented the ‘‘lost transfer’’ possibility to
avoid the problem that player As might immediately withhold
positive transfers after observing a single non-repayment. All our
subjects in the main experiment are in the role of player A. They
are paired with player Bs for whom repayment decisions were pre-
recorded, i.e. player Bs decided in how many of a total of 20
rounds they were going to make a repayment. Thus, player Bs
made decisions in line with their true prosocial preferences. Player
As were aware of the fact that they were paired with a player B
whose decisions had been pre-recorded and also about the
possibility that their transfers might get ‘‘lost’’ in 20% of the cases.
The use of pre-recorded player B decisions is necessary to avoid
an important confound. If player A would interact simultaneously
with a given player B they could vary transfers strategically to
influence player B’s future behavior [28]. Specifically, by
conditioning transfers on B’s previous repayments, A can generate
reputational incentives for B to repay [29]. Thus, in repeated
simultaneous interactions in this context a repayment is no longer
a clear signal of a player B’s prosocial preferences, because a
purely selfish player B may also repay due to reputational
incentives and hide his or her true type [30]. To investigate player
A’s pure learning process about a partners’ prosocial preferences
within a reinforcement-learning framework, we eliminated these
strategic elements by using pre-recorded decisions of player B.
Player A could infer that repayments from player B can be
interpreted as a pure signals of true prosocial preferences.
All player As in our main experiment were matched with one of
two types of player Bs: a prosocial one, from whom player As
received a repayment in 14 out of the 20 rounds, and a relatively
selfish one from whom player As received a repayment in only 6
out of 20 rounds. Player As were not aware of the fact that we
deliberately pre-selected a prosocial and a more selfish partner. All
transfer decisions had real monetary consequences for player As,
and they were told in the instructions that their decisions also have
an influence on player Bs’ payoff, which retains the social aspect if
this experimental setting. Furthermore, as player As do not have
any information about the social preferences of player Bs at the
outset, they have to rely on their everyday knowledge about how
people would behave in such a social interaction situation. They
can then use this information and learn, trial by trial, through
positive or negative social feedback about player Bs’ prosocial
preferences.
In sum, the fact that player As can not influence player Bs’
decisions allows us to exclude any strategic motives that might
confound reward-learning behavior and allows to test in an clean
way whether L-DOPA administration interacts with player As’
DAT1 polymorphism in modulating learning about a partner’s
prosocial preferences.
Pre-Recording of Player B Decisions
To pre-record the player Bs’ decisions, we conducted a session
involving the same task design (without drug administration)
several weeks before the main experiment. Each participant had to
indicate in how many of 20 rounds he, in the role of player B,
would make a repayment. After player B had decided how often
he wanted to repay, the computer randomly distributed the
repayment decisions across the 20 rounds of the experiment. This
procedure allowed us to collect a large number of player B
repayment decisions.
Optimal Transfer Decision
Player A can choose transfers x M [0,10]. Player B receives the
transfer with probability of 0.8. In this case he can decide to retain
all the money or to repay the amount of 2x to equalize payoffs.
Player A’s transfer is lost with a probability of 0.2, meaning that
player B cannot make a repayment. Player A’s optimal transfer x
depends on the probability p with which player B repays when he
receives the transfer. Player A’s expected profit E[p] is given as
follows:
E½p~10{xzp:0:8:2x~10z(1:6p{1)x
The expected profit is strictly increasing in x as long as p.5/8.
Thus, if p is larger than 5/8, then player A profits most if he always
transfers his whole endowment (that is, 10 MUs). If p is smaller
than 5/8, then it is best to always transfer nothing (that is, 0 MUs).
If p equals 5/8, player A is indifferent, as all possible transfers yield
the same expected payoff. From this follows that profit-maximizing
player As who are matched with prosocial player B should transfer
their full endowment in each round, whereas player As who are
matched with a selfish player B should not transfer anything.
Measures of Drug Related Side Effects
Side effects were assessed using visual analog scales [31] and
were recorded prior to substance administration and before the
trust game was performed. Items in the scale were alert/drowsy,
calm/excited, strong/feeble, muzzy/clear-headed, well coordinat-
ed/clumsy, lethargic/energetic, contented–discontented, trou-
bled–tranquil, mentally slow/quick-witted, tense/relaxed, atten-
tive/dreamy, incompetent/proficient, happy/sad, antagonistic/
amicable, interested/bored and withdrawn/gregarious. These
dimensions were presented as 10 cm lines on a computer screen
and volunteers marked their current state on each line with a
mouse click. In line with previous research [32], the factors
‘‘alertness’’, ‘‘contentedness’’, and ‘‘calmness’’ were calculated
from these items.
Statistical Analysis
Our statistical analysis is based on analysis of variance, Mann-
Whitney tests and Spearman rank correlations. All tests are two-
tailed tests. We examined the impact of partner type [with a binary
indicator for partner type indicating whether the player A was
confronted with the pre-recorded decisions of a prosocial player B
( = 1) or a ore selfish player B ( = 0)], L-DOPA [with a binary
indicator for L-DOPA indicating whether the subject received L-
DOPA ( = 1) or placebo ( = 0)], genotype [(with a binary indicator
for subjects who carry a 9/10R genotype ( = 1) or a 10/10R
genotype ( = 0)], and interactions between these variables in a
univariate three-way ANOVA on the investor’s total earnings in
the task. Further analyses included the reinforcement learning
model parameters alpha and theta as dependent variables
(Materials S1).
Dopamine and Learning about Others’ Prosociality
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Results
Learning About a Partners Prosocial Preferences
We found that subjects (total n = 200) successfully learn over
time who is prosocial and who is not (Figure 1a). Average transfers
increase over time when interacting with a prosocial partner
(n = 101) and decrease with a selfish partner (n = 99). Analysis of
transfers (in MUs) as the dependent variable using partner type
(prosocial, selfish) as a between-subjects and rounds (1–20) as a
within-subject factor showed a significant interaction effect of
round6partner type (F(10.2,198)=10.20, p,0.001, partial eta-
square = 0.049). Transfers began to differ according to partner
type, on average, by the ninth trial (Figure 1a: prosocial vs selfish
type, Z = 3.00, p,0.003). Applying a standard reinforcement
learning model [33] to the transfers revealed that the model
adequately predicts player As’ learning behavior (Figure 1a,
Materials S1, Figure S2).
Dopaminergic Effects on Learning Performance
Having established that player As successfully learn about the
prosocial preferences of their partners, we looked at the overall
learning performance as measured by As’ total earnings in the
task. The repayment probability of the pre-selected prosocial type
ensured that transferring the full endowment (10 MUs) is the
strategy maximizing expected profits (total earnings of 280 MUs),
while the repayment probability of the pre-selected selfish type
implied that transferring nothing would have maximized expected
profits (total earnings of 200 MUs). We found that L-DOPA
effects on earnings depend on DAT1 genotype and on partner
type (interaction effect L-DOPA6DAT16partner type on total
earnings, F(1,176)= 4.65, p,0.032, partial eta-square = 0.026).
When subjects faced a prosocial partner, we found a significant
interaction effect of L-DOPA6DAT1 genotype on learning
performance (F(1,89) = 9.66, p,0.003, partial eta-square = 0.098).
Specifically, L-DOPA increased learning performance in subjects
carrying the 10/10R genotype, assumed to be associated with
lower endogenous striatal dopamine levels, with placebo subjects
earning an average of 260.2 MUs, while subjects on L-DOPA
earned 270.9 MUs (Figure 1b: placebo vs L-DOPA in 10/10R
genotype group, Z=2.022, p,0.043). Conversely, we found that
L-DOPA administration reversed this learning effect in those
subjects carrying the 9/10R genotype, which is assumed to be
Figure 1. Average player As’ transfers across rounds and resulting earnings. (a) Player As’ transfers in each round during interactions with a
prosocial (grey dots) respective selfish (black dots) player B over 20 rounds of the task. Player As increase their transfers over the 20 rounds when
paired with a prosocial player B and decrease their transfers while interacting with a selfish player B. The learning curves represent the predicted
transfers by the reinforcement learning model for interactions with a prosocial (grey line) and selfish (black line) partner. Hence, player As learn to
adapt their transfers according to player Bs’ prosocial preferences. (b/c) Dopaminergic modulation of learning performance defined as the total
earnings accumulated by player As. (b) When paired with a prosocial partner, player As who carry the 10/10R DAT1 genotype (lower striatal
dopamine levels, n = 50) improve their learning performance under the influence of L-DOPA (placebo: n = 22; L-DOPA: n = 28). Player As who carry the
9/10R DAT1 genotype (higher striatal dopamine levels, n = 43) show an impaired performance after L-DOPA administration (placebo: n = 27; L-DOPA:
n = 16). (c) Dopaminergic effects are absent when player As are paired with a selfish partner. Horizontal lines indicate average total earnings of player
As, separately for L-DOPA and placebo groups and the 9/10R (placebo: n = 19; L-DOPA: n = 26) and the 10/10R DAT1 (placebo: n = 23; L-DOPA: n = 23)
genotype carriers. Vertical lines indicate standard errors of the mean.
doi:10.1371/journal.pone.0067820.g001
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associated with higher endogenous striatal dopamine levels, with
placebo subjects earning 265.7 MUs and L-DOPA subjects
earning an average of 249.3 MUs (Figure 1b: placebo vs L-DOPA
in 9/10R genotype group, Z = 1.961, p,0.050). We found no
dopaminergic effects on learning performance when investors
faced a more selfish partner (Figure 1c: main and interaction
effects of two-way ANOVA, all p values .0.454).
Because the observed pharmacogenetic effect on earnings might
also result from player As level of prosociality before the task
started (that is, their baseline prosociality), we checked whether
there were differences across drug, player B type, and genotype in
player As transfers in the first round of the task, but found no
evidence for this (three-way ANOVAs, all p values .0. 202).
Finally, controlling for side effects of L-DOPA administration
using visual analogue scales, the reported interaction effect of L-
DOPA6DAT1 on player As’ learning performance about
interactions with a prosocial partner remains significant
(F(1,86) = 7.76, p,0.007, partial eta-square = 0.083).
Dopamergic Effects on Reinforcement Learning
Parameters
The total earnings in our task reflect an important outcome
variable of the player As’ learning process, but this measure says
little about how learning takes place. To this end, we modeled
player As’ learning within the framework of reinforcement
learning [33]. The model employed here (Materials S1), disen-
tangles two essential processes. The first process (captured by the
model’s learning rate parameter) determines how strongly a given
feedback from a player B (that is positive or no returns) changes
the subjective value of the available transfer options (0–10 MUs).
A low learning rate implies that the player Bs’ feedback has a
relatively small impact on player As’ decision in the next round,
whereas a high learning rate implies a relatively larger impact. The
second process is captured by the sensitivity parameter. This
parameter specifies the exploration-exploitation trade-off of
reinforcement learning [34]. A high sensitivity parameter implies
a strong focus on the transfer option with the highest subjective
value, whereas a low sensitivity parameter implies that all transfer
options will be chosen with substantial probability. For example, a
given player A may assign the highest subjective value to the
transfer of 10 MUs after a few interactions with a prosocial
partner. If he persists with transferring 10 MUs for the remaining
rounds, his sensitivity parameter would be high. If he continues by
exploring alternative options (0–9 MUs), his sensitivity parameter
would be low.
In analogy to previous findings on reinforcement learning in
non-social contexts [4], we did not observe any dopaminergic
effects on the learning rate parameter (all p values .0.316). In
contrast, we found a clear interaction of L-DOPA and player As’
DAT1 genotype on the sensitivity parameter (Figure 2:
F(1,89)=7.923, p,0.006, partial eta-square = 0.082). When ex-
pressing the sensitivity parameter for easier interpretation as the
probability of choosing the transfer with the highest expected value
(Figure S1), L-DOPA compared to placebo administration
decreases the probability of choosing the transfer with the highest
subjective value in 9/10R genotype carriers by 8.6 percentage
points. On the other hand, this probability increases by 13.3
percentage points for 10/10R individuals following L-DOPA
administration.
Discusssion
We show that a manipulation of the dopaminergic system
modulates learning about a partners’ prosocial preferences. In
particular, we found that L-DOPA administration improves this
learning process in carriers of the 10/10R genotype, which is
assumed to be linked to lower endogenous striatal dopamine levels,
but impairs learning in people who carry the 9/10R genotype,
which is assumed to be linked to higher endogenous dopamine
levels.
Our findings resemble an inverted-U shaped relationship
between dopamine levels and learning performance that is that
dopaminergic drugs such as L-DOPA might stimulate the
dopaminergic system to optimal or overdosed levels in individuals
with low vs. high baseline dopamine system functioning [35]. This
may be understood in the context of theoretical and empirical
accounts suggesting that optimal tuning of dopamine function in
the prefrontal cortex [36], and as demonstrated recently also in the
striatum [37], is vital for a variety of cognitive functions. In other
words, there seems to be a critical range of dopamine stimulation
for better behavioral performance, while behavioral performance
above or below this critical range of dopamine stimulation
deteriorates [38].
By modeling player As’ behavior within the framework of
reinforcement learning we found no evidence of a dopaminergic
modulation of the learning rate parameter, but found a clear
interaction of L-DOPA and player As’ DAT1 genotype on the
sensitivity parameter. Furthermore, the modeling results suggest
that administering L-DOPA to investors who carry a 9/10R
genotype confers lower earnings in the task by decreasing their
sensitivity for exploiting the subjectively best transfer. In other
words, it appears that the pharmacogenetic manipulation mostly
affects the degree to which appropriately learned prosocial values
of the other partner are used at the point of choice and not the
capacity to update expectations on the basis of novel feedback
during the learning phase. These results concur with recent
computational models which emphasize a role for striatal
dopamine in modulating the sensitivity parameter rather than
the learning rate [39] and is also empirically supported by the
finding that hyper-dopaminergic mice with a reduced expression
Figure 2. Pharmacogenetic effect on the sensitivity parameter.
Administration of L-DOPA increases the sensitivity for making transfers
that subjectively provide the largest expected return in player As who
carry the 10/10R DAT1 genotype (lower endogenous striatal dopamine
levels) (placebo: n = 22; L-DOPA: n= 28), but decreases this sensitivity in
those who carry the 9/10R DAT1 genotype (higher endogenous striatal
dopamine levels) (placebo: n = 27; L-DOPA: n= 16). Horizontal lines
indicate mean values of the sensitivity parameter, separately for L-DOPA
and placebo groups and the 9/10R and the 10/10R DAT1 genotype
carriers. Vertical lines indicate standard errors of the mean.
doi:10.1371/journal.pone.0067820.g002
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of striatal DAT (DAT knockdown mice) display a diminished
capacity to exploit learning opportunities, as represented by a
lower value of their sensitivity parameter [40].
Our finding that individuals with highest striatal dopamine
levels (9/10R carriers who received L-DOPA) benefit the least
from transfers to a prosocial partner is also intriguing from a
clinical perspective. Psychotic patients exhibiting paranoia show
pronounced distrust of others, even though they reside in a
conducive environment as part of their treatment regimen in the
clinic. Current theories hold that psychosis might result from a
disturbance in error-related updating of inferences and beliefs
about the world [41] caused by an overactive mesolimbic
dopaminergic system [42]. Indeed, a recent study found that
psychotic individuals exhibit reduced reciprocal trust in response
to positive feedback from a trustworthy trustee [43]. Thus,
although speculative, these findings generally support our claim.
Finally, our finding might have relevance for the pharmacological
treatment of Parkinson’s disease, as patients who carry the 9/10R
genotype are reported to face an increased risk of suffering from
psychosis in response to L-DOPA treatment, a finding which was
interpreted to result from overly high striatal dopamine levels [23].
The fact that we found no dopaminergic effects on learning
performance when player As’ faced a selfish partner adds novel
pharmacogenetic evidence on the ongoing debate over dopamine’s
role in appetitive and aversive instrumental learning [4,44]. While
the absence of repayment by player B following a high transfer is
associated with monetary loss and is thought to be an aversive
social stimulus for player A, positive returns are associated with a
monetary gain and are considered to be a rewarding social
stimulus [45]. We thus found evidence for a dopaminergic
modulation of learning from appetitive, but not from aversive
stimuli. This is again in line with dopaminergic drug challenge
studies showing a relative selectivity for processing appetitive
rather than aversive stimuli in probabilistic learning tasks both in
healthy subjects [4], and patients affected with Parkinsons disease
[6].
The probabilistic learning paradigms in non-social contexts
employed by research in Parkinsons disease patients and healthy
subjects have some commonality with our task in the sense that
investors are required to make stimulus-outcome associations
based on probabilistic feedback from the interaction partner.
Thus, the fact that the DAT occurs mostly in the striatum, but
only in low concentrations in other areas of the brain [14],
together with our finding that the DAT1 polymorphism modulates
L-DOPA effects on learning about a partners’ prosocial prefer-
ences might be an indication that there might also be a common
regional neurochemical process at work during reinforcement
learning based on social feedback as it is the case for non-social
feedback [13]. However, as player As in the current drug study
might still have tried to infer player Bs (past) intentions or attitudes
to predict repayments when making investments, these inferences
might have relied upon a cognitive mentalizing system on top of
neural systems such as the reward circuitry [46]. Hence, whether
our pharmacogenetic effect is uniquely related to social interac-
tions or rather reflects a relatively broad probabilistic learning
mechanism that guides behavior both in social and non-social
contexts is a topic for further studies.
Summary and Conclusions
In sum, while dopaminergic drugs have been shown to affect
human reward learning in non-social contexts via modulation of
striatal activity, imaging studies of social interactions have shown
that activation of the striatum tends to facilitate human
cooperative behaviors. Here we show a causal role of the
dopaminergic system in learning about others prosocial prefer-
ences. Exogenous dopamine improves learning performance in
subjects who carry the 10/10R genotype, assumed to be associated
with lower striatal dopamine levels, and impairs learning
performance in people with the 9/10R genotype, assumed to
confer higher striatal dopamine levels. These effects might not be
related to specifically social situations, but may rather result from a
dopaminergic modulation of a general reward learning mecha-
nism. Our findings are not only relevant for fundamental research,
but potentially constitute a stepping stone for new ways of
understanding psychiatric disorders that link the dopaminergic
system with distorted perceptions of others prosocial attitudes.
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